ReviewAdvances in therapy2013

The dipeptidyl peptidase (DPP)-4 inhibitors for type 2 diabetes mellitus in challenging patient groups.

David KountzPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.